Case Series: Recovery of Chemotherapy-Related Acute Heart Failure by the Combined Use of Sacubitril Valsartan and Wearable Cardioverter Defibrillator: A Novel Winning Combination in Cardio-Oncology
Maria Laura Canale(Ospedale Versilia), Giancarlo Casolo(Fondazione Toscana Gabriele Monasterio), G. Solarino(Ospedale Versilia), Jacopo Del Meglio(Ospedale Versilia), Federico Simonetti(Ospedale Versilia), Andrea Camerini(Ospedale Versilia), Katia Coviello(Ospedale Versilia), Carlo Tessa(Azienda USL Toscana Nord Ovest), Nicola Maurea(Cancer Institute (WIA)), Irma Bisceglia(Azienda Ospedaliera San Camillo-Forlanini), Elio Venturini(Azienda Usl Toscana Centro)
Cited by 9
Related Papers
Detection of Significant Coronary Artery Disease by Noninvasive Anatomical and Functional Imaging
|Circulation Cardiovascular Imaging|2015|412
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
|Cardiovascular Diabetology|2021|368
Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
|Journal of Clinical Oncology|2017|186
Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer
|Journal of Cardiac Failure|2011|116
Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience
|Cancer Biology & Therapy|2010|108